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The lipid-linked oligosaccharides synthesized in the presence of the cr-glucosidase inhibitors, l-deoxynojiri- 
mycin (DJN) and N-methyl-1-deoxynojirimycin (MDJN), were compared in IEC-6 intestinal epithelial cells 
in culture. HPLC analysis of the oligosaccharides obtained before and after exhaustive jack bean a-mannosi- 
dase digestion indicates that control and MDJN-treated cells synthesize similar amounts of Glc,Man,Glc- 
NAc,-PP-dolichol. In contrast, the formation of this compound is greatly reduced in DJN-treated cells, the 
major lipid-linked oligosaccharide found being Man,GlcNAc,-PP-dolichol. The decreased availability of 
the preferred donor for protein glycosylation may account for the impaired glycosylation and secretion of 
certain glycoproteins in the presence of DJN. 
I-Deoxynojirimycin 
1. INTRODUCTION 
N-Methyl-I-deoxynojirimycin Glucosidase inhibitor 
Processing 
Dolichol-linked oligosaccharide 
Several compounds that inhibit the biosynthesis 
of N-linked complex oligosaccharides by preven- 
ting the action of glucosidases and mannosidases 
involved in processing of the oligosaccharides have 
recently been described [l-7]. These inhibitors are 
very useful for studying the role of oligosac- 
charides in glycoproteins, provided that their mode 
of action is clearly understood. 
In previous work, we showed that DJN and 
MDJN prevent the synthesis of complex oligosac- 
charides in IEC-6 intestinal epithelial cells, and 
cause the accumulation of a mixture of oligosac- 
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Abbreviations: DJN, I-deoxynojirimycin; MDJN, N- 
methyl-1-deoxynojirimycin; endo H, endo-,&N- 
acetylglucosaminidase H; R, retention time of each 
..dosaccharide divided by the retention time of stan- 
dard Glc3Man9GlcNAc 
charides containing l-3 glucose residues and 7-9 
mannose residues. A much larger proportion of 
the oligosaccharides formed in the presence of 
MDJN contained 3 glucose residues compared to 
those formed in the presence of DJN [a]. 
Here we report the effects of DJN and MDJN 
on the synthesis of lipid-linked oligosaccharides in 
IEC-6 cells, and demonstrate that DJN great- 
ly reduces the synthesis of glucosylated lipid- 
linked oligosaccharides, particularly of 
Glc3MansGlcNAcz-PP-dolichol, whereas normal 
amounts of the latter are formed in MDJN-treated 
cells. 
2. MATERIALS AND METHODS 
The source of chemicals and of D-[2-3H]man- 
nose was described previously [a]. Confluent 
IEC-6 rat intestinal epithelial cells were incubated 
in lOO-mm dishes for different periods of time as 
described in [B]. After labeling, the medium was 
removed, 3 ml methanol was added to the dishes, 
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the cells were scraped, transferred with 3 ml 
methanol into tubes, and chloroform was added to 
yield chloroform/methanol (2 : 1, v/v). The pellet 
was extracted successively with 2 ml chloroform/ 
methanol (2: 1 Y v/v), 0.5 ml methanol, 3 times 
3 ml water, 0.5 ml methanol, and finally 3 times 
3 ml chloroform/methanol/water (10 : 10 : 3, by 
vol.). The chloroform/methanoI/water fraction 
was dried with air and hydrolyzed in 1 ml of 0.1 M 
HCl for 30 min at 90°C. It was then neutralized 
with NaOH, desalted through coupled columns of 
AG 5OW-X8 (H+ form, 200-400 mesh) and 
AGl-X8 (formate form, 200-400 mesh), and 
1yophiIized. The hydrolysate was treated with endo 
H and chromatographed on a column of Bio-Gel 
P-6. The fractions containing labeled oligosac- 
charides were pooled, subjected to HPLC with 
14C-labeled standards, before and after exhaustive 
digestion with jack bean a-mannosidase, as 
described [8]. 
3. RESULTS AND DISCUSSION 
3.1. Effect of the inhibitors on the incorporation 
of D-[2-3HJrnannose into lipid-linked 
oligosaccharides 
The effects of DJN (5 mM) and MDJN (2 mM) 
on the labeled lipid-linked oligosaccharides were 
examined at different times, varying from 15 min 
to 2 h, after incubation of IEC-6 cells with D- 
[2-3H]mannose, under the conditions used 
previously to study the protein-bound oligosac- 
charides [S]. The incorporation of mannose into 
these oligosaccharides was slightly higher in the 
presence of MDJN than in the control, whereas it 
was either the same or slightly inhibited in the 
presence of DJN. 
When the labeled oligosaccharides were frac- 
tionated by HPLC, the major product found in 
untreated cells and in cells incubated with MDJN 
was eluted with the “C-labeled Glc3ManqGlcNAc 
standard (fig. lA,B). In DJN-treated cells, 
however, little radioactivity corresponded to 
Glc3MangGlcNAc, and the major labeled fraction 
was eluted earlier than the standard glucose- 
containing oligosaccharides (R = 0.8) (fig.lC). 
Since this elution position corresponds to that of 
MansGlcNAc [8], these results indicate that non- 
glucosylated lipid-bound oligosaccharide is found 
in DJN-treated cells. 
30 
150 
5 100 
D 
50 
i____L 
n 
0 
0 20 40 60 60 
?-- - 
123 i 
III ! 
0 20 40 60 60 
ISOf 
““,I ____.&,“.\,I \” i.. ]j\>,. j 
0 20 40 60 80 
FRACTION NUMBER 
Fig.1. HPLC of oligosaccharides released from lipid- 
linked oligosaccharides. IECd cells were incubated for 
15, 30 and 120 min with lO,&i/ml D-[2-3H]mannose. 
The chloroform/methanol/water (10: 10: 3, by vol.) 
fractions were obtained and pooled. The oligosac- 
charides were released by mild acid treatment, treated 
with endo H and fractionated by HPLC as indicated in 
section 2. A, control cells; B, cells treated with 2 mM 
MDJN; C, cells treated with 5 mM DJN. The inhibitors 
were added 5-6 h before D-[2-3H]mannose. Arrows 
indicate the elution positions of the r4C-labeled stand- 
ards: 1, Glc,Man9GlcNAc; 2, Gic2~an9GicNAc and 3, 
Glc~MangGlcNAc. Different aliquots were applied to the 
HPLC column in A, B and C. Similar inhibition of 
Glc3Man9GlcNAc labeling by DJN was observed after 
5 min incubation (unpublished). 
3.2. ~-~a~nosiduse treatment of the oligosac- 
charides 
To distinguish between glucosylated and non- 
glucosylated oligosaccharides, exhaustive a- 
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mannosidase treatment was performed, followed 
by HPLC of the products. We showed in [8] that 
this procedure separates GlcjMamGlcNAc, 
GlczMan&lcNAc and GlciMamGlcNAc, and pro- 
vides an estimate of the number of glucose residues 
originally present in the oligosaccharides. In con- 
trol cells, 60% of the radioactivity present in the 
oligosaccharides was released as mannose; this 
value is close to the 56% expected from standard 
GlcJMangGlcNAc. Furthermore, the major 
oligosaccharide product of a-mannosidase treat- 
ment corresponded to Glc3MamGlcNAc (table 1). 
Similar results were obtained for MDJN-treated 
cells, demonstrating that the major lipid-linked 
oligosaccharide formed in these two cases is 
Glc3MansGlcNAcz. In DJN-treated cells, however, 
an increased proportion of labeled mannose was 
released by Lu-mannosidase, indicating the presence 
of non-glucosylated oligosaccharides. In addition, 
there was a large decrease in the proportion of 
oligosaccharides containing 3 glucose residues 
(table 1). These results indicate that the major 
lipid-linked oligosaccharide fraction (R = 0.8) 
found in DJN-treated cells contains primarily 
MansGlcNAc, and some GlciMansGlcNAc, 
GlczMangGlcNAc and Glc3Man7GlcNAc [8]. 
3.3. Conclusions 
The above results demonstrate that MDJN- 
treated cells synthesize normal amounts of 
Glc3MangGlcNAcz-PP-dolichol which is the major 
oligosaccharide donor required for protein 
glycosylation [9]. DJN, on the other hand, greatly 
reduces the amount of glucosylated lipid-linked 
oligosaccharide formed, and the proportion of 
Glc3MangGlcNAcz-PP-dolichol. In previous work, 
an inhibitory effect of DJN on the incorporation 
of D-[2-3H]mannose into lipid-linked oligosac- 
charides in medium containing pyruvate was 
observed [lo], but the present results demonstrate 
that even with little inhibition of total lipid- 
oligosaccharide synthesis, a major effect of DJN 
is the greatly reduced synthesis of 
Glc3MansGlcNAcz-PP-dolichol precursor. The 
mechanism whereby this inhibition occurs in vivo 
is unclear since DJN does not inhibit the formation 
of dolichol-P-glucose and dolichol-PP-oligosac- 
charide from UDP-[14C]glucose in calf pancreas 
microsomes (unpublished). 
It is evident therefore that the effects of DJN on 
glycoproteins in vivo may result not only from its 
action on processing lucosidases, but also from its 
inhibitory effects on glucosylation of lipid 
oligosaccharides. Since Glc3Man9GlcNAcz is the 
preferred substrate for transfer to protein [9], the 
decrease in Glc3Man9GlcNAcz-PP-dolichol donor 
in DJN-treated cells may account for the in- 
complete glycosylation of certain proteins which 
has recently been reported [ 1 l-131. It is also possi- 
ble that the decreased transport from rough en- 
doplasmic reticulum to Golgi and the decreased 
secretion of certain glycoproteins which has been 
observed [ 1 l-141 are caused by conformational 
changes resulting from this incomplete glycosyla- 
tion. It may also be responsible for the lower pro- 
portion of protein-bound oligosaccharides con- 
taining 3 glucose residues obtained in the presence 
of DJN [8]. Conclusions derived from studies with 
Table 1 
Products of cy-mannosidase treatment of oligosaccharides 
Additions Concentration 
(mM) 
GIG,” 
dpm (Q) 
Glcz= Glcs= Mannoseb 
None _ 130 (4) 80 (3) 960 (33) 1760 (60) 
MDJN 2.0 30 (1) 180 (4) 1980 (43) 2430 (53) 
DJN 5.0 210 (9) 160 (5) 360 (11) 2400 (75) 
a Glcr, GlcrMafiGlcNAc; Glcz, Glc2Man4GlcNAc; Glc3MatiGlcNAc 
b Under these conditions mannose and Mar@1,4GlcNAc disaccharide are not separated 
The endo H-treated oligosaccharides were exhaustively digested with cY-mannosidase and the 
products were fractionated by HPLC (see section 2) 
31 
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DJN regarding the role of carbohydrate in 
glycoproteins should therefore be assessed in light 
of the above findings. 
ACKNOWLEDGEMENTS 
Supported by the Medical Research Council of 
Canada and by the National Cancer Institute of 
Canada. 
REFERENCES 
HI 
PI 
I31 
[41 
Elbein, A.D., Solf, R., Dorling, P.R. and Vosbeck, 
K. (1981) Proc. Natl. Acad. Sci. USA 78, 
7393-7397. 
Saunier, B., Kilker, R.D. jr, Tkacz, J.S., Quaroni, 
A. and Herscovics, A. (1982) J. Biol. Chem. 257, 
14155-14161. 
Datema, R., Romero, P.A., Legler, 0. and 
Schwarz, R.T. (1982) Proc. Natl. Acad. Sci. USA 
79, 6787-6791. 
Pan, Y .T., Hori, H., Saul, R., Sanford, B.A., 
Molyneux, R.J. and Elbein, A.D. (1983) 
Biochemistry 22, 3975-3984. 
[51 
WI 
171 
181 
191 
UOI 
illI 
1121 
1131 
[I41 
Romero, P.A., Datema, R. and Schwarz, R.T. 
(1983) Virology 130, 238-242. 
Fuhrmann, U., Bause, E., Legler, G. and Ploegh, 
H. (1984) Nature 307, 755-758. 
Elbein, A.D., Mitchell, M., Sanford, B.A., 
Fellows, L.E. and Evans, S.V. (1984) J. Biol. 
Chem. 259, 12409-12413. 
Romero, P.A., Saunier, B. and Herscovics, A. 
(1985) Biochem. J., in press. 
Hubbard, S.C. and Ivatt, R.J. (1981) Annu. Rev. 
Biochem. 50, 555-583. 
Datema, R., Romero, P.A., Rott, R. and Schwarz, 
R.T. (1984) Arch. Virol. 81, 25-39. 
Gross, V., Andus, T., Tran-Thi, T.-A., Schwarz, 
R.T., Decker, K. and Heinrich, P.C. (1983) J. Biol. 
Chem. 258, 12203-12209. 
Lodish, H.F. and Kong, N. (1984) J. Cell Biol. 98, 
1720-1729. 
Lemansky, P., Gieselmann, V., Hasilik, A. and 
Von Figura, K. (1984) J. Biol. Chem. 259, 
10129-10135. 
Peyrieras, N., Bause, E., Legler, G., Vasilov, R., 
Claesson, L., Peterson, P. and Ploegh, H. (1983) 
EMBO J. 2, 823-832. 
32 
